Moody's lowers its rating on Dentsply (XRAY) to Baa2, maintaining a stable outlook on the maker...

|By:, SA News Editor

Moody's lowers its rating on Dentsply (XRAY) to Baa2, maintaining a stable outlook on the maker of dental devices. The ratings agency took note of the extra debt the firm is picking up as part of the $1.8B deal to acquire AstraZeneca's (AZN) dental impant business.